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Abstract
Background: Medication reconciliation has been identified as an important intervention to minimize the incidence
of unintentional medication discrepancies at transitions in care. However, there is a lack of evidence for the impact
of information technology on the rate and incidence of medication discrepancies identified during care transitions.
This systematic review was thus, aimed to evaluate the impact of electronic medication reconciliation interventions
on the occurrence of medication discrepancies at hospital transitions.
Methods: Systematic literature searches were performed in MEDLINE, PubMed, CINHAL, and EMBASE from
inception to November, 2015. We included published studies in English that evaluated the effect of information
technology on the incidence and rate of medication discrepancies compared with usual care. Cochrane’s
tools were used for assessment of the quality of included studies. We performed meta-analyses using
random-effects models.
Results: Ten studies met our inclusion criteria; of which only one was a randomized controlled trial.
Interventions were carried out at various hospital transitions (admission, 5; discharge, 2 and multiple
transitions, 3 studies). Meta-analysis showed a significant reduction of 45 % in the proportion of medications
with unintentional discrepancies after the use of electronic medication reconciliation (RR 0.55; 95 % CI 0.51 to
0.58). However, there was no significant reduction in either the proportion of patients with medication
discrepancies or the mean number of discrepancies per patient. Drug omissions were the most common
types of unintended discrepancies, and with an electronic tool a significant but heterogeneously distributed
reduction of omission errors over the total number of medications reconciled have been observed (RR 0.20;
95 % CI 0.06 to 0.66). The clinical impact of unintended discrepancies was evaluated in five studies, and there
was no potentially fatal error identified and most errors were minor in severity.
Conclusion: Medication reconciliation supported by an electronic tool was able to minimize the incidence of
medications with unintended discrepancy, mainly drug omissions. But, this did not consistently reduce other
process outcomes, although there was a lack of rigorous design to conform these results.
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Background
Medication reconciliation has been recognized as an im-
portant approach to improve the quality use of medi-
cines by reducing the burden of medication
discrepancies at care transitions [1–4]. Medication dis-
crepancies often occur at transitions in care when pa-
tients are admitted to and discharged from a hospital,
and are responsible for more than half of the medication
errors [5]. Unintentional medication discrepancies are
highly prevalent at hospital transitions — for example,
two-thirds of inpatients have at least 1 unexplained
changes to medication at hospital admission [6], and up
to one-third of the medication discrepancies could have
a potential for patient harm [7]. Clinically important
medication discrepancies could also represent an im-
portant cause of adverse drug events (ADEs) [8–10] and
healthcare resource utilization [11, 12] during transitions
in care.
Medication reconciliation has been adopted and cham-
pioned by a number of patient safety organizations. Medi-
cation reconciliation (MedRec) is defined by the Institute
for Healthcare Improvement (IHI) as “the process of iden-
tifying the most accurate list of a patient’s current medi-
cines including the name, dosage, frequency and route —
and comparing them to the current list in use, recognizing
and documenting any discrepancies, thus resulting in a
complete list of medications” [13]. Depending on the re-
sources available, various approaches to the medication
reconciliation intervention are employed internationally,
including the use of electronic reconciliation tools [14–16],
standardized forms [17, 18], collaborative models [19, 20],
and pharmacy-led programs [21, 22]. Particularly, the use
of information technology (IT) can increase the accuracy
of documentation used for the medication reconciliation,
and is now commonly used to facilitate the reconciliation
process [23]. One of the main advantages of the electronic
medication reconciliation is that the best medication his-
tory can be ensured through information sharing [24]. IT-
related interventions might reduce medication discrepan-
cies at hospital transitions [25], but there are fewer studies
supporting this evidence. Additionally, previous reviews
[26, 27] included medication reconciliation interventions
carried out by physicians, nurses, pharmacists and elec-
tronic medication reconciliation and evaluated both clinical
(e.g. hospital readmissions) and process outcomes (e.g.
medication discrepancies), but did not specifically assess
the impact of electronic medication reconciliation. In the
literature, numerous reviews [28–30] examined the impact
of electronic prescribing on medication errors and ADEs;
however, no reviews have yet examined the impact of IT
on medication discrepancies identified through the medi-
cation reconciliation process. The purpose of this study
was thus, to systematically evaluate the available literature
on the effectiveness of electronic medication reconciliation




This systematic review and meta-analysis was performed
according to the PRISMA statement [31], including a
checklist to ensure consistent reporting of a systematic
review. The search included articles from inception of
the databases up to week 3 of November 2015, which
were obtained through an extensive search of the follow-
ing electronic databases: MEDLINE (1946), EMBASE
(1966), CINAHL (1937) and PubMed (1946). Some of
the key words or Medical Subject Heading (MeSH)
terms used in the search were: “medication reconcili-
ation,” “medication discrepancies,” “medication errors,”
“medication history,” “electronic health records,” “pa-
tient admission,” “patient discharge,” “patient transfer,”
and “hospital”. Details on the specific search terms and
combinations are provided in the Additional file 1. The
literature search also involved manual search of bibliog-
raphies of the identified papers. Only studies published
in English were included. No restrictions were imposed
on year of publication.
Study selection
Two independent reviewers (ABM, TBA) screened ab-
stracts and titles for eligibility. When the reviewers felt
that the abstract or title was potentially useful, full cop-
ies of the articles were retrieved and considered for eligi-
bility by the reviewers. When discrepancies occurred
between reviewers, the final decision was made based on
the agreement of these reviewers.
To be included in the selection, studies required to
present all of the following: studies which reported data
related to the effectiveness of electronic medication
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reconciliation intervention, and provided data on medi-
cation discrepancies or errors. Medication discrepancies
were defined as one or more differences in (dosage, fre-
quency, drug, and route of administration), as described
by the IHI [13], between the current and previous medi-
cation (s) a patient was taking. We excluded studies with
a focus on other types of medication errors (e.g. pre-
scribing errors) that were identified through the non-
reconciliation process. The included interventions had
to start in the hospital and must be performed primarily
by an electronic tool with the aim of minimizing medi-
cation discrepancies during transitions in hospital care.
Regardless of the study design, the intervention must be
compared with another group that received usual or
standard care. ‘Usual care’ was defined as any care in
which medication reconciliation was not supported by
an electronic tool, or if there was not any previous for-
mal electronic medication reconciliation in place. Only
full-text published articles from peer-reviewed journals
were eligible for inclusion. Along with duplicate refer-
ences and studies with a different focus, the following
types of studies were excluded: other medication recon-
ciliation practices (e.g. pharmacist-led medication recon-
ciliation programs not supported by technology), case
studies, systematic reviews, qualitative outcomes, and
non-research articles. Abstracts from conferences and
full-texts without raw data available for retrieval were
not considered.
Data extraction and quality assessment
Two study authors (ABM, TBA) independently extracted
data in a standardized form, including quality assess-
ment of randomized studies [32]. Observational studies
were evaluated for their quality by applying criteria from
the ACROBAT-NRSI statement including: 1) bias due to
confounding, 2) bias in selection of participants into the
study, 3) bias in measurement of interventions, 4) bias
due to departures from intended interventions, 5) bias
due to missing data, 6) bias in measurement of out-
comes, and 7) bias in selection of reported results [33].
The response for each criterion was judged based on a
scale of low, moderate, serious, critical and no informa-
tion. Any disagreements between the authors were re-
solved with mutual consensus. In general, we abstracted
the following data: author, year of study, country of origin,
study setting and design, number of study participants,
target of transition, description of the intervention, length
of the study, medications assessed for discrepancy and
whether those discrepancies were explicitly described as
unintentional changes to medications after clarification
was sought from the medical team and/or patient. The
primary outcome of interest was the rate and incidence of
medication discrepancies, expressed in terms of the pro-
portion of patients with medication discrepancies, or as a
mean number of discrepancies per patient, or the propor-
tion of medications/medication orders with discrepancies
over the total number of medications reconciled. The sec-
ondary outcome was an assessment of the clinical rele-
vance of identified medication discrepancies.
Statistical analysis
Meta-analyses of studies were done according to the
Cochrane Handbook for Systematic Review of Interven-
tions [34], using the Review Manager (RevMan) Ver-
sion 5.3. (Copenhagen: The Nordic Cochrane Centre,
the Cochrane Collaboration, 2014. (http://tech.cochra-
ne.org/revman/). A random-effects model was
employed, and the results were presented in forest
plots. For studies providing dichotomous data, the
relative risk (RR) with its 95 % confidence interval
(CI) was calculated by comparing medication discrep-
ancy rates between the intervention and comparison
group. Whereas for continuous data, we calculated
the mean differences with their associated 95 % confi-
dence intervals. We assessed statistical heterogeneity
by observing τ2, χ2 (Q), I2 and p-value. We attempted
to explore the possible sources of heterogeneity
through subgroup analysis; however, the inclusion of
too few studies in each of the outcomes studied pre-
cluded us from carrying out such analyses. Sensitivity
analysis was carried out to assess the stability of
pooled estimates when any of the studies were with-
drawn from the analysis. P-value < 0.05 was consid-
ered as statistically significant. Publication bias was
not assessed with funnel plots because the number of




The initial electronic database search resulted in a
total of 1672 articles. An additional 5 studies were
identified through hand-search of the reference lists
of included studies. On removal of duplicate records,
1283 studies were screened for title and abstract. Of
these, 1216 studies did not meet the selection criteria.
Of the 67 studies obtained in full-text, only 10 studies
met the inclusion criteria (Fig. 1). The main reasons
for exclusion were either due to reporting of a differ-
ent outcome of interest (n = 21) or medication recon-
ciliation was not supported by information technology
(n = 12) (Additional file 2).
Characteristics and quality of included studies
Study characteristics
Detail characteristics of the included studies are sum-
marized in Table 1. The included studies were pub-
lished between 2006 and 2015, and entirely performed
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in the USA [35–41] and Spain [42–44]. Only one
study [40] was a randomized controlled trial. The
remainder were non-randomized studies, mainly
employing a pre-post study design. All except one
study [41] were performed in academic centres or ter-
tiary care hospitals. Two studies [37, 40] were con-
ducted at multiple centres. Nine of the 10 included
studies involved a total of 21,486 patients of various
sample sizes ranging from 100 to 19,476 patients/dis-
charges. The length of study periods ranged from 10
to 70 weeks. The included studies were heterogeneous
for interventions, outcomes, target of transitions and
methods for measuring outcomes. Electronic medica-
tion reconciliation interventions were more variable
with regard to the place of transition, and com-
menced at various points of hospital transition, such
as admission [35, 37, 42–44], discharge [36, 41] and
multiple transitions [38–40]. Besides the development
of an electronic medication reconciliation tool, some
studies utilized a multifaceted intervention, including
involvement of a computerized reminder alert [35],
process re-design (e.g. work-flow) and staff training
[40, 44], and integration of an electronic tool with an
already existing computerized physician order entry
programs [40, 42, 43]. Types of medications explored
for medication discrepancy were varied among the
studies — for example, other than prescription medi-
cations, some studies [35, 38, 39, 44] also considered
non-prescription and over-the-counter medications.
Exceptionally, there was one study [36] which was
specifically focused on antibiotics only. All but one
study [38] clearly differentiated unintentional from
intentional changes to medications from their report,
or explicitly described in their methods as medication
discrepancies were unintentional after clarification
was sought from the medical team and/or patient.
Five studies [37, 38, 42–44] evaluated both the
primary and secondary outcomes. However, Schnipper
et al. [40] assessed only unintentional medication
discrepancies with a potential for patient harm.
Fig. 1 PRISMA flow diagram of included studies
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Yes At least 1 unintended
discrepancy: 20 % (Pre) vs.
1.4 % (Post)
Drug omission was the most








Pre-post 200 patients Discharge Electronic discharge
medication reconciliation,
staff training
NR Antibiotics Yes At least 1 antibiotic error:
23 % (Pre) vs. 11 % (Post)
Percentage of medications
with errors: 30 % (Pre) vs.
15 % (Post)
Dosage errors were the most
common type of medication






NRCT 469 patients Nursing home to hospital
transfer (admission)
Structured review NR Prescription
medications
Yes No difference, with and
without EHR, in medication
discrepancies (mean
difference 0.02; 95 % CI - 0.81
to 0.85) and a high-risk dis-
crepancies (mean difference
−0.18; 95 % CI −0.22 to 0.58)
per hospitalization episode,
and an ADE caused by a
medication discrepancy (OR
0.96; 95 % CI 0.18 to 5.01)
46 % of prescribing
discrepancies resulted in ADEs









tool integrated in a CPOE
program
6 months NR Yes Percentage of medications
with discrepancies: 7.24 %
(Pre) vs. 4.18 % (Post)
Drug omission was the most
frequent unintended
discrepancy in both phases














Yes At least 1 unintended
discrepancy: 40.2 % (Pre) vs.
38.1 % (Post)
Medications with unintended




















Table 1 Characteristics of included studies (Continued)
Of all unintended
discrepancies, 144 (86.2 %)
were due to drug omissions






























Admission, discharge Multidisciplinary MedRec







Yes Percentage of medications
with unintended
discrepancies: 90 % (Pre) vs.
47 % (Post) [SU]; 57 % (Pre) vs.
33 % (Post) [MU]
On the surgical unit, omitted
home medications (reduced
from 21 % of orders to 0 %),
omitted inpatient medications
(from 8 to 1 %) and in the
medical unit, omitted home
and inpatient medications







RCT 322 patients Admission, discharge IT designed MedRec




novel IT and process re-
design, supportive roles (e.g.
training)
NR NR Yes Mean number of medication
discrepancies with a potential
for harm per patient: 1.44 (C)






Pre-post 100 patients Discharge Formation of a medication
list from pre-existing elec-
tronic sources and reconcili-
ation of discharge





intervention vs. control in at
least 1 outcome in this
category; i.e., drug frequency,
dose and therapeutic
duplication
Resolution of discrepancies in
frequency increased by 65 %
Resolution of discrepancies in
dosages improved by 60 %
Resolution of therapeutic
duplication was addressed in

































Yes Percentage of medications
with unintended
discrepancies:3.5 % (Pre) vs.
1.8 % (Post)
At least 1 unintended
discrepancy: 23.7 % (Pre) vs.
14.6 % (Post)
Drug omission was the most
common unintended
discrepancy
Omission error: 2.6 % (Post) vs.
2 % (Pre)
ADE adverse drug event, BPMH best possible medication history, CPOE computerized physician order entry, C control, EHR electronic health record, I intervention, IT information technology, MedRec medication



















Table 2 Summary of risk of bias assessment for non-randomised studies according to A Cochrane Risk of Bias Assessment Tool for Non-randomized Studies of Interventions
(ACROBAT-NRSI) [33]
References Bias due to
confounding






Bias due to departures
from intended
interventions
Bias due to missing data Bias in
measurement of
outcomes




Agrawal 2009 [35] Serious Low Low No information No information Serious Low Serious
Allison 2015 [36] Low Low Moderate No information Low Moderate Moderate Moderate
Boockvar 2010 [37] Low Moderate Low Moderate No information Moderate Low Moderate
Gimeneze- Manzorro 2011
[42]
Serious No information Low No information No information Moderate Low Serious
Gimeneze- Manzorro 2015
[43]
Moderate Low Serious No information Moderate Moderate Low Moderate
Kramer 2007 [38] Serious Low Low Moderate No information Serious Serious Serious
Murphy 2009 [39] No
information
No information Moderate Moderate No information Moderate Moderate Moderate
Poole 2006 [41] No
information
Moderate Low Low No information Serious Moderate Serious
Zoni 2012 [44] Low Low Moderate No information Low Moderate Low Moderate




















The quality assessments of included studies were per-
formed separately for randomized and non-randomized
studies. Schnipper et al. [40] was the only randomized
study assessed for its quality using the EPOC [32] risk of
bias assessment tool. Except that the medication discrep-
ancies were not assessed blindly, this study [40] was found
to have a low risk of bias in terms of randomization, allo-
cation concealment, baseline outcomes and characteris-
tics, attrition, contamination and selection biases. The
quality of non-randomized studies is described in Table 2.
Using the ACROBAT-NSRI assessment tool, the overall
bias among the studies were classified as moderate in five
studies [36, 37, 39, 43, 44], whereas the remaining studies
were judged to have a serious risk of bias.
Effectiveness of electronic MedRec interventions
Of the 10 studies that reported data on medication dis-
crepancies, 8 studies targeting various transitions (ad-
mission, 5 studies; discharge, 1 study and multiple
transitions, 2 studies) were included in the meta-
analyses. Two studies [38, 41] did not contribute data in
a suitable form for the meta-analysis. In one of these
studies, [38] the aim was to evaluate the efficiency of an
electronic tool in facilitating the reconciliation process,
and did not specifically give data regarding the effective-
ness of the intervention. A pharmacist-nurse initiated
admission and discharge medication reconciliation by
Kramer et al. [38] showed an improvement in medica-
tion history completeness after implementation of an
electronic tool; that is, patients in the post-
implementation group took significantly more prescrip-
tion and non-prescription medications, and the total
number of medications significantly exceeded the num-
ber taken by the pre-implementation group. Poole et al.
[41] was the other study not included in the meta-
analysis due to the outcomes evaluated. Poole et al. [41]
demonstrated an effective computerization of the medi-
cation reconciliation process, and found an improve-
ment in the safety of patients by minimizing medication
discrepancies in frequency, dose and therapeutic dupli-
cation at the time of discharge — resolution of discrep-
ancies increased by 65, 60 and 58 %, respectively.
Meta-analyses were performed in-terms of the propor-
tion of patients with medication discrepancies, or as
mean number of medication discrepancies per patient or
incidence of medications with discrepancies over the
total number of medications. Also, the most common
type (s) of discrepancies were elaborated and synthesized
quantitatively.
Proportion of patients with medication discrepancies
Only four studies [35, 36, 43, 44] reported the propor-
tion of patients with at least one medication discrepancy.
Fig. 2 Meta-analysis of the effectiveness of electronic medication reconciliation on the proportion of patients with medication discrepancies at
hospital transitions
Fig. 3 Meta-analysis of the effectiveness of electronic medication reconciliation on the incidence of medications with unintentional discrepancies
over the total number of medications reconciled at hospital transitions
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Figure 2 shows the forest plot of 4 studies expressing
medication discrepancies dichotomously (proportion
of patients with medication discrepancies). The
pooled result of such studies on this outcome showed
no difference in medication discrepancies between the
intervention and usual care (RR 0.37; 95 % CI 0.08 to
1.70; p = 0.2), and this was associated with substantial
heterogeneity (I2 = 98 %). However, when Agrawal et
al. [35] study was removed, the sensitivity analysis
showed modest heterogeneity without affecting the
significance difference (RR 0.70; 95 % CI 0.46 to 1.09;
p = 0.12, I2 = 48 %).
Proportion of medications with unintended discrepancy
Four studies [39, 42–44] were able to report the inci-
dence of unintended discrepancies over the total number
of medications reconciled. One study [39] reported data
for two different hospital units (surgical and medical
unit) and included these data in the analysis as separate
interventions. Meta-analysis of data from the five elec-
tronic medication reconciliation interventions conducted
at various transitions showed a significant reduction of
the incidence of medications with discrepancies in
favour of the intervention (RR 0.55; 95 % CI 0.51 to
0.58; p < 0.00001, I2 = 0 %) (Fig. 3).
Mean medication discrepancies per patient
Only three studies [37, 40, 43] reported the mean number
of medication discrepancies per patient as an outcome.
The pooled result for these three medication reconcili-
ation interventions did not show a significant difference
between the intervention and usual care groups (mean dif-
ference −0.18; 95 % CI −0.45 to 0.09; p = 0.18, I2 = 35 %)
(Fig. 4).
Type (s) of medication discrepancies
Seven studies [34–36, 38, 41–43] reported the most com-
mon type (s) of medication discrepancies. Except in one
study [36], the most common type of medication discrep-
ancy identified by the majority of the studies was omission
error. Four studies involving five interventions gave data
in terms of the percentage of omission errors over the
total number of medications reconciled, and were in-
cluded in the meta-analysis. Here, Murphy et al. [39] re-
ported data for two different hospital units; i.e., surgical
and medical unit, and included in the analysis as two co-
horts of interventions. Two studies [35, 36] in this meta-
analysis were excluded because of an absence of a com-
mon denominator in the calculation of the pooled esti-
mate. Meta-analysis of the five interventions expressing
the proportion of omission errors over the total number
of medications showed a significant reduction of 80 % in
favour of the intervention (RR 0.20; 95 % CI 0.06 to 0.66;
p = 0.008, I2 = 96 %) (Fig. 5). On sensitivity analysis, this ef-
fect is greatly influenced by Murphy 2009 [SI] study [39];
removal of this intervention showed a non-significant and
heterogeneously distributed reduction in omission errors
(RR 0.43; 95 % CI 0.17 to 1.04; p = 0.06, I2 = 91 %).
Fig. 4 Meta-analysis of the effectiveness of electronic medication reconciliation on unintentional medication discrepancies expressed in terms of
the mean number of medication discrepancies per patient
Fig. 5 Meta-analysis of the effectiveness of electronic medication reconciliation on the percentage of omission errors over the total number of
medications reconciled
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Clinical significance of medication discrepancies
The clinical impact of medication discrepancies was
reported in five studies [37, 38, 42–44]. One study
[40] reported medication discrepancies with a poten-
tial for harm only. Most of the studies described that
the majority of the unintended discrepancies did not
cause any harm to the patient, and were grade C in
severity according to the National Coordinating
Council for Medication Error Reporting and Preven-
tion (NCC MERP) classification [45]; that is, the error
reached the patient but caused no harm. Two studies
reported [37, 46] actual patient harm requiring inter-
vention or prolonged hospitalization in 7 to 55 % of
medication discrepancies. One study [42] compared
the incidence of severe medication errors before and
after implementation of an electronic tool, and found
that there was a significant reduction in severity of
medication discrepancies post-implementation (5.3 %
vs. 2.4 %, p < 0.0001). Schnipper et al. [40] showed
fewer medication discrepancies with the potential to
cause serious harm, such as re-hospitalization in the
intervention than the usual care group, 0.27 vs. 0.34
per patient, respectively. For severity assessment, four
of the five studies adopted a medication error index
employed by the NCC MERP [45], and evaluators in




This systematic review on electronic medication reconcili-
ation interventions did not identify a consistent impact in
minimizing the occurrence of unintentional medication dis-
crepancies during transitions in hospital care. Specifically,
pooled estimates showed a 63 % reduction in patients with
medication discrepancies; however, this was not statistically
significant, nor was the mean number of medication dis-
crepancies per patient. But, the intervention had signifi-
cantly reduced the percentage of medications with
unintended discrepancy and drug omissions over the total
number of medications reconciled. However, it should be
noted that the findings were derived from a subset of stud-
ies that reported each outcome of interest. Drug omissions
were the most common types of unintended discrepancies
identified through an electronic tool. The clinical import-
ance of unintended discrepancies was evaluated in five
studies. There was no potentially fatal error identified, and
most errors were minor in severity.
Comparison with previous research
To the best of our knowledge, this is the first systematic
review and meta-analysis that focused on the impact of
electronic medication reconciliation on the rate and in-
cidence of unintentional medication discrepancies at
transitions in hospital care. Previous reviews [26, 27]
Table 3 Clinical significance of unintentional medication discrepancies
Author, year Tool for clinical significance
evaluation
Clinical judgment determined by Results
Boockvar 2010 [37] NCC MERP [45] Discussion between 2 physicians
or 1 physician and 1 pharmacist
46 % of prescribing discrepancies causing ADEs were
asymptomatic, 52 % were associated with symptoms
and 3 % caused a prolonged or an additional hospital
stay.




NCC MERP [45] Consensus between the pharmacist
and the medical coordinator
Grade C, 79.2 %
Grade D, 13.6 %
Grade E, 7.1 %
Gimeneze-Manzorro
2011 [42]
NCC MERP [45] Pharmacist discuss with medical
coordinators
Most errors were grade C in severity in both phases.
Severe errors: Pre-implementation, 96/1,823 (5.3 %);
Post-implementation, 48/1,958 (2.4 %)
Kramer 2007 [38] Nickerson et al. 2005 [48] NR Pre-implementation: 3 MEs (2 category B errors, 1
category C error)
Post-implementation: 4 MEs (3 category B errors, 1
category C error)
Zoni 2012 [44] NCC MERP [45] Consensus between the pharmacist
and the medical coordinator
Most of the unintended discrepancies would cause no
harm to the patient.
In the pre-implementation, there were 2 patients where
either patient monitoring would be required or the pa-
tient would suffer temporary damage.
MEs medication errors, NCC MERP National Coordinating Council for Medication Error Reporting and Prevention, NR not reported
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evaluating the importance of medication reconciliation
overall had not consistently reported the effectiveness of
medication reconciliation interventions. However, latest
reviews regarding medication reconciliation interven-
tions carried out through pharmacist assessment have
shown an impact on some of the clinical (e.g. all-cause
readmission) and process outcomes (e.g. medication dis-
crepancies) [46, 47]. For instance, our previous study
[47] showed a substantial reduction of 66 % in patients
with medication discrepancies favouring pharmacy-led
interventions carried out at single transitions (either ad-
mission or discharge). However, the present study
showed a non-significant reduction in either of the out-
comes studied; that is, the proportion of patients with
medication discrepancies, or mean number of medica-
tion discrepancies per patient. Unlike the previous re-
view [47], the present study did not differentiate effects
due to place of transition, and in that study, multiple
transitions interventions were less effective in reducing
medication discrepancies. In the current study, there
were some studies with multiple transitions included in
the meta-analyses. This might have brought differences
in effect and significance.
In the present study, drug omissions were the most
frequent errors and this is consistent with other pub-
lished works [6, 7]. It is not surprising to observe dosage
errors as the commonest errors identified in a study by
Alison et al. [36]; the type of medications studied for dis-
crepancy were antibiotics, and this group of medications
are mainly indicated for acute treatment of infections.
As Zoni et al. [44] allude to, there exists a relationship
between chronic medicines use and the occurrence of
unintended discrepancy, mainly drug omissions.
This study identified only a few of the unintended dis-
crepancies having clinical impact on patient care. How-
ever, data from previous studies [27, 46] reported more
clinically important discrepancies in 28 to 91 % of medi-
cation discrepancies. This variation might be because
these reviews [27, 46] largely involved multifaceted inter-
ventions, including people and technology.
Implications for practice and policy
While with information technology it is possible to share
medication information and facilitate medical consultation
between healthcare professionals, it has also resulted in re-
duction of medication errors and ADEs [28–30]. Most im-
portantly, computerized physician order entry (CPOE)
programs complemented with a medication reconciliation
service might be an important approach in preventing the
various types of medication errors occurred in a hospital
setting. While a CPOE system would be able to fill the
lack of prescriber’s knowledge, it would not able to detect
unintentional omission of medications the patient was
taking at home during transitions in hospital care [35]. It
was thus, a CPOE program paired with a medication rec-
onciliation service might be able to bridge the gaps in con-
tinuity of patient care, and further ensures a
comprehensive medication history of patients. However,
careful integration of the tool is very important for suc-
cessful implementation of computerized medication rec-
onciliation services. For example, Schnipper et al. [40] has
depicted differences in the extent of integration of the
medication reconciliation tool into a computerized provider
entry applications between hospitals, and this has brought
huge differences in effect. In general, effective medication
reconciliation likely requires a multifaceted approach in-
volving people, process, technology and that technology in-
terventions alone may not consistently reduce errors.
Strengths and limitations of the study
The main strength of this study was the exploration of
the effectiveness of an electronic tool on unintentional
medication discrepancies with broader inclusion criteria
across a range of hospital transitions, not limited to spe-
cific transition (s). We did not select studies based on
patient population (paediatric, adult) and study design.
We imposed no limit on the year of publication, and we
searched an extensive articles of the international litera-
ture. However, this study is not without limitations. The
main limitation is that there were fewer published studies
of sufficient scientific quality that adequately addressed
the effects of electronic medication reconciliation on un-
intentional medication discrepancies. There was also het-
erogeneity among studies for interventions, outcomes,
target of transition, study duration and methods for meas-
uring outcomes. The number and types of medications
evaluated for medication discrepancy varied among the
studies. Also, the heterogeneity of the intervention needs
to be considered — for example, some interventions were
integrated into in an already existing computerized phys-
ician order entry programs and there were some sort of
workflow redesign and staff teaching. The number and
type of team who initiated an electronic interventions for
medication reconciliation, and the person (s) who rou-
tinely assessed medication discrepancies were also varied.
In the meta-analysis of patients with at least one discrep-
ancy, one study of low scientific quality [35] had a great
number of patients and un-proportionate sample in the
intervention group and, as a result, contributed to a large
extent to the pooled result and heterogeneity. The pooled
estimate in this outcome did not significantly reduce the
incidence of medication discrepancies and the confidence
intervals crossed the line of the usual care group and
were rather wide. We included only published studies
in English, and the number of included studies were
not enough to assess publication bias that might be
arisen from language restriction and non-inclusion of
non-published data.
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Implications for future study
There is a lack of high-quality studies with rigorous de-
signs that investigate the impact of electronic medication
reconciliation on medication discrepancies. Additionally,
it is important that future studies should assess the clinical
impact of medication discrepancies for complete evalu-
ation of the interventions. A clear separation of intentional
from unintentional medication discrepancies, and further
verification of the identified discrepancies from the re-
sponsible practitioner and/or team should be noted in
their report. Overall, future research should be involved at
more rigorous evaluations of the interventions and evalu-
ation of commercially available electronic medication rec-
onciliation tools, aimed at minimizing unintentional
medication discrepancies at transitions in hospital care.
Studies in the paediatrics population were not identified,
and studies in this regard are also urgently needed.
Conclusion
Medication reconciliation supported by information
technology was found to be an important tool for min-
imizing the percentage of medications with uninten-
tional discrepancies over the total number of
medications reconciled. Of particular note, omission er-
rors were reduced in a great extent after the use of an
electronic tool. But, implementation of an electronic
medication reconciliation did not favour the intervention
in other process outcomes; that is, patients with at least
one medication discrepancy and mean number of medi-
cation discrepancies per patient. However, limitations in
the available literature such as lack of well-designed
studies precluded us from concluding that no effect ex-
ists. Careful integration of electronic interventions with
other medication reconciliation components (i.e., sup-
portive roles and processes) to improve outcomes of
interest would be more appropriate.
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